Concord Biotech Approves 1:1 Bonus Issue, Doubling Paid-Up Equity Capital
Concord Biotech Ltd 路 Bonus Issue 路 05 Nov 2026, 11:33 pm
Concord Biotech Approves 1:1 Bonus Issue, Doubling Paid-Up Equity Capital Concord Biotech approved the allotment of 10,46,16,204 fully paid-up bonus equity shares of Rs. 1 each in a 1:1 ratio to shareholders registered as of the 4th Nov'26 record date. Following this allotment, the company's paid-up equity share capital doubled from Rs. 10.46 cr to Rs. 20,92,32,408, comprising 20,92,32,408 equity shares of Rs. 1 each.
Original exchange filing (PDF)
More announcements from Concord Biotech Ltd
- Transcript of Q2 - FY27 Earnings call held on October 28, 2026 路 03 Nov 2026
- Earning Call Recording- For the Second Quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to be held on 03rd and 4th November, 2026. 路 28 Oct 2026
- Investor''s presentation on unaudited standalone and consolidated financial results for the second quarter and half year ended on September 30, 2026 路 28 Oct 2026
- The Board of Directors at its meeting held on October 27, 2026 has fixed Wednesday, November 04, 2026 as record date for issuance of Bonus equity shares in the ratio of 1:1. 路 28 Oct 2026
- Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30, 2026. 路 28 Oct 2026
- Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 28 Oct 2026
- The Board of Directors of the Company, at its meeting held today i.e. Tuesday, October 27, 2026, has inter-alia considered and approved the Un-audited financial results for the quarter .... 路 28 Oct 2026
